Philip Harvey

Department of Psychiatry, Mount Sinai School of Medicine, United States of America

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Psychiatry > Schizophrenia & Other Psychoses (since 21 March 2007)

All recent recommendations

• 3.0
  Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate.
  Recommended by Philip Harvey
  
• 6.0
  An investigation of the relationship between activation of a social cognitive neural network and social functioning.
  Recommended by Philip Harvey
  
• 6.0
  Premorbid IQ in schizophrenia: a meta-analytic review.
  Recommended by Philip Harvey
  
• 3.0
  Galantamine for the treatment of cognitive impairments in people with schizophrenia.
  Recommended by Philip Harvey
  
• 3.0
  The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
  Recommended by Philip Harvey
  
• 3.0
  Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
  Recommended by Philip Harvey
  
• 3.2
  Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia.
  Recommended by Antonio Lobo, Philip Harvey
  
• 3.0
  Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial.
  Recommended by Philip Harvey